AJP - Renal AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (August 20, 2008). doi:10.1152/ajprenal.90243.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/4/F1207    most recent
90243.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ren, Y.
Right arrow Articles by Carretero, O. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ren, Y.
Right arrow Articles by Carretero, O. A
Submitted on April 7, 2008
Revised on August 12, 2008
Accepted on August 12, 2008

Heme oxygenase metabolites inhibit tubuloglomerular feedback (TGF)

Yilin Ren1, Martin A D'Ambrosio1, Hong Wang1, Ruisheng Liu1, Jeffrey L Garvin1, and Oscar A Carretero2*

1 Henry Ford Hospital
2 henry Ford Hospital

* To whom correspondence should be addressed. E-mail: ocarret1{at}hfhs.org.

Tubuloglomerular feedback (TGF) is the mechanism by which the macula densa (MD) senses increases in luminal NaCl concentration and sends a signal to constrict the afferent arteriole (Af-Art). The kidney expresses constitutively heme oxygenase-2 (HO-2), and low levels of HO-1. HOs release carbon monoxide (CO), biliverdin and free iron. We hypothesized that renal HOs inhibit TGF via release of CO and biliverdin. Rabbit Af-Arts and attached MD were simultaneously microperfused in vitro. TGF response was determined by measuring Af-Art diameter before and after increasing NaCl in the MD perfusate. When HO activity was inhibited by adding stannous mesoporphyrin (SnMP) to the MD perfusate, TGF response increased from 2.1±0.2 µm to 4.1±0.4 µm (p = 0.003, control vs SnMP, n = 7). When a CO-releasing molecule, CORM-3 (50 µM) was added to the MD perfusate, TGF response decreased by 41%, from 3.6±0.3 µm to 2.1±0.2 µm (p< 0.001, control vs CORM-3, n = 12). When CORM-3 at 100 µM was added to the perfusate, it completely blocked TGF response, from 4.2±0.4 µm to -0.2±0.3 µm (p < 0.001, control vs CORM-3, n = 6). When biliverdin was added to the perfusate, TGF response decreased by 79%, from 3.4±0.3 µm to 0.7±0.4 µm (p = 0.001, control vs biliverdin, n = 6). The effects of SnMP and CORM-3 were not blocked by inhibition of nitric oxide synthase. We concluded that renal HO inhibits TGF probably via release of CO and biliverdin. HO regulation of TGF is a novel mechanism that could lead to a better understanding of the control of renal microcirculation and function.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.